Laurel Habel to Confounding Factors (Epidemiology)
This is a "connection" page, showing publications Laurel Habel has written about Confounding Factors (Epidemiology).
Connection Strength
0.475
-
Statins and Reduced Risk of Liver Cancer: Evidence for Confounding. J Natl Cancer Inst. 2016 10; 108(10).
Score: 0.135
-
Confounding by alcohol use: benzodiazepines and risk of liver cancer. Br J Clin Pharmacol. 2015 May; 79(5):872-3.
Score: 0.124
-
Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. Cancer Causes Control. 2009 Dec; 20(10):1821-35.
Score: 0.085
-
Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst. 2004 Oct 06; 96(19):1467-72.
Score: 0.060
-
Barbiturates and lung cancer: a re-evaluation. Int J Epidemiol. 1999 Jun; 28(3):375-9.
Score: 0.041
-
Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
Score: 0.029